Non-Squamous Non-Small Cell Lung Cancer Recruiting Phase 3 Trials for Nivolumab (DB09035)

Also known as: Non-squamous Non-small Cell Lung Cancer

IndicationStatusPhase
DBCOND0036730 (Non-Squamous Non-Small Cell Lung Cancer)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03906071Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous NSCLCTreatment